市场调查报告书
商品编码
1190860
过滤器完整性测试市场——COVID-19 的增长、趋势、影响和预测 (2023-2028)Filter Integrity Test Market - Growth, Trends, and Forecasts (2023 - 2028) |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
由于生物製药行业的增长和研发活动支出的增加,预计过滤器完整性测试市场在预测期内的复合年增长率为 4.6%。
根据美国药物研究与製造商协会 (PhRMA) 的数据,药物开发通常需要 10-15 年时间,平均成本约为 26 亿美元。 此外,2016 年,製药和生物製药公司的全球研发支出约为 1.567 亿美元。 此外,2017 年,PhRMA 制定了一项新标准,要求每年至少平均投资约 2 亿美元。 预计这些努力将推动对过滤器完整性测试的需求。
*在过滤器完整性测试市场,由于产品技术的出现及其对手动的主导地位,自动化部分有望成为主导部分。 手动过滤器测试仪完全依靠操作员来操作设备,因此难以维护记录,而自动化则无需操作员参与,从而最大限度地减少或消除了污染。
*2019年,Sartorius AG开发了下游产品Sartocheck(R) 5 Plus Filter Integrity Tester。 可以检测到人为错误、危险环境和不正确的测试设置。 Airtechnic International 还发布了 100X 自动过滤效率计,专为製药製造中涉及的过滤介质和滤芯而设计。 因此,预计这些因素将推动这一特定领域的市场。
由于对製药和生物製药相关研发活动的投资不断增加,预计北美地区将在全球过滤器完整性测试市场占据主要市场份额。 根据 2016 年药物研究与製造商协会 (PhRMA) 的数据,美国在研发支出中所占比例很高,约为 58%。 此外,欧洲製药工业协会联合会发现,美国的研发支出约为 524.18 亿美元。 因此,这些因素有望对过滤器完整性测试市场产生积极影响。
过滤器完整性测试市场是分散的,由几家主要参与者组成。 目前主导该市场的公司包括 Merck KGaA、Sartorius AG、MEISSNER FILTRATION PRODUCTS INC、ThermoFisher Scientific Inc、Donaldson Company、PARKER HANNIFIN CORP、Eaton Corporation PLC、Pall Corporation、3M 和 Filter Integrity Ltd. increase。
The filter integrity test market is expected to register a CAGR of 4.6% during the forecast period, due to the growing biopharmaceutical industry and the increasing expenditure on R&D activities. According to the Pharmaceutical Researchers and Manufacturers of America (PhRMA), a drug development generally takes 10 to 15 years and it costs on an average of about USD 2.6 billion. Furthermore, in 2016, worldwide spending on R&D by the pharmaceutical and biopharmaceutical companies was around USD 156.7 million. Moreover, in 2017, PhRMA established new criteria according to which there should be a minimum average investment of about USD 200 million per year. Such initiatives are expected to drive the demand for a filter integrity test.
* The automated segment is expected to be a dominant segment in the filter integrity test market, owing to the developing technology in the product and its advantages over manual. It involves no operator, thus minimal or no contamination whereas in manual filter tester handling of the equipment is totally dependent on operators and maintenance of record becomes difficult.
* In 2019, Sartorius AG developed a product Sartocheck® 5 Plus filter integrity tester for downstream processing. It is able to detect human errors, hazardous environments, and improper test set-ups. Also, Air Techniques International introduced 100X Automated Filter Efficiency Tester designed for filter media and cartridges that are involved in pharmaceutical production. Thus, these factors are expected to propel the market in this particular segment.
The North American region is expected to hold a major market share in the global filter integrity test market, due to increasing investments in R&D activities related to pharmaceuticals and biopharmaceuticals. According to the Pharmaceutical Researchers and Manufacturers of America (PhRMA) data of 2016, United States has the highest share of around 58% in terms of R&D expenditure. Furthermore, according to the European Federation of Pharmaceutical Industries and Associations, the R&D expenditure was around 52,418 million USD in United States. Hence, these factors are expected to impact positively on the filter integrity test market.
The filter integrity test market is fragmented and consists of several major players. Some of the companies that are currently dominating the market are Merck KGaA, Sartorius AG, MEISSNER FILTRATION PRODUCTS INC., ThermoFisher Scientific Inc., Donaldson Company, PARKER HANNIFIN CORP., Eaton Corporation PLC, Pall Corporation, 3M, and Filter Integrity Ltd.